X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1398) 1398
ophthalmology (1276) 1276
humans (1261) 1261
intravitreal injections (1014) 1014
ranibizumab (904) 904
male (758) 758
female (752) 752
macular degeneration (715) 715
bevacizumab (674) 674
vascular endothelial growth factor a - antagonists & inhibitors (646) 646
aged (642) 642
vascular endothelial growth factor (583) 583
angiogenesis inhibitors - therapeutic use (480) 480
aflibercept (476) 476
tomography, optical coherence (460) 460
middle aged (456) 456
visual acuity (452) 452
endothelial growth-factor (429) 429
aged, 80 and over (412) 412
treatment outcome (408) 408
angiogenesis inhibitors - administration & dosage (393) 393
retrospective studies (376) 376
diabetic retinopathy (345) 345
eye diseases (345) 345
follow-up studies (340) 340
wet macular degeneration - drug therapy (318) 318
retina (303) 303
recombinant fusion proteins - administration & dosage (300) 300
receptors, vascular endothelial growth factor - administration & dosage (287) 287
genetic structures (286) 286
fluorescein angiography (285) 285
macular edema - drug therapy (284) 284
care and treatment (275) 275
recombinant fusion proteins - therapeutic use (270) 270
edema (267) 267
receptors, vascular endothelial growth factor - therapeutic use (257) 257
visual acuity - physiology (240) 240
intravitreal injection (232) 232
age-related macular degeneration (230) 230
diabetes (223) 223
therapy (223) 223
optical coherence tomography (219) 219
patients (215) 215
ranibizumab - administration & dosage (213) 213
age (212) 212
degeneration (211) 211
diabetic macular edema (209) 209
injection (208) 208
prospective studies (204) 204
diabetic retinopathy - drug therapy (203) 203
analysis (193) 193
choroidal neovascularization (188) 188
macular edema (187) 187
physiological aspects (187) 187
intravitreal aflibercept (186) 186
sense organs (182) 182
choroidal neovascularization - drug therapy (179) 179
macular degeneration - drug therapy (177) 177
time factors (174) 174
eye (172) 172
ranibizumab - therapeutic use (170) 170
medicine & public health (164) 164
anti-vegf (163) 163
photodynamic therapy (161) 161
wet macular degeneration - diagnosis (161) 161
endothelial growth factors (160) 160
retinopathy (158) 158
intravitreal bevacizumab (157) 157
macular edema - etiology (155) 155
pharmacology & pharmacy (153) 153
neovascularization (152) 152
outcomes (150) 150
acuity (146) 146
vegf (145) 145
drug therapy (143) 143
animals (142) 142
fundus oculi (142) 142
clinical trials (141) 141
wet macular degeneration - physiopathology (140) 140
efficacy (134) 134
intravitreal ranibizumab (134) 134
eyes (132) 132
studies (132) 132
research (127) 127
antibodies, monoclonal, humanized - therapeutic use (125) 125
surgery (124) 124
trial (121) 121
safety (118) 118
bevacizumab - administration & dosage (116) 116
macular edema - diagnosis (113) 113
dose-response relationship, drug (112) 112
dropsy (111) 111
abridged index medicus (110) 110
adult (110) 110
angiogenesis (110) 110
retinal vein occlusion (110) 110
angiogenesis inhibitors - adverse effects (108) 108
visual acuity - drug effects (108) 108
review (104) 104
medical imaging (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1709) 1709
German (32) 32
French (18) 18
Spanish (8) 8
Turkish (3) 3
Czech (2) 2
Japanese (2) 2
Korean (2) 2
Polish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 11, pp. 2247 - 2254
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 08/2015, Volume 99, Issue 8, pp. 1055 - 1059
Journal Article
Ophthalmology, ISSN 0161-6420, 10/2015, Volume 122, Issue 10, pp. 2044 - 2052
Journal Article
JAMA, ISSN 0098-7484, 05/2017, Volume 317, Issue 20, pp. 2072 - 2087
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 01/2019, Volume 39, Issue 1, pp. 61 - 68
To evaluate functional and anatomical outcomes after a switch from intravitreal bevacizumab to aflibercept in patients with persistent diabetic macular edema.... 
VISUAL-ACUITY | MANAGEMENT | aflibercept | optical coherence tomography | VEGF | anti-vascular endothelial growth factor | switch | TRIAL | THERAPY | PREDICTORS | bevacizumab | OPHTHALMOLOGY | RETINOPATHY | RANIBIZUMAB | INTRAVITREAL AFLIBERCEPT | diabetic macular edema | Complications and side effects | Eye diseases | Care and treatment | Diabetes
Journal Article